Amedisys’ (AMED) “Equal Weight” Rating Reiterated at Stephens

Amedisys (NASDAQ:AMED – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by research analysts at Stephens in a research note issued on Wednesday,Benzinga reports. They presently have a $101.00 price objective on the health services provider’s stock. Stephens’ price objective suggests a potential upside of 8.86% from the company’s current price. Amedisys Stock […]